Tharp v. Acacia Commc'ns, Inc.

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• citing Lirette v. Shiva Corp., 27 F. Supp. 2d 268, 283 (D. Mass. 1998) (requiring a securities plaintiff to show that “sales by insiders were in fact unusual or suspicious in amount or timing.”

Source: CourtListener parenthetical corpus (CC0).

Cites

29 cases in this archive are cited by this case; the 20 most cited are listed.

• Bell Atlantic Corp. v. Twombly
  Supreme Court· 2007-05-21· cited 146,720×
• Tellabs, Inc. v. Makor Issues & Rights, Ltd.
  Supreme Court· 2007-06-21· cited 6,044×
• Affiliated Ute Citizens of Utah v. United States
  Supreme Court· 1972-06-12· cited 1,751×
• Herman & MacLean v. Huddleston
  Supreme Court· 1983-01-24· cited 1,450×
• Shaw v. Digital Equipment Corp.
  First Circuit· 1996-05-07· cited 855×
• Glassman v. Computervision Corp.
  First Circuit· 1996-07-31· cited 495×
• Greebel v. FTP Software, Inc.
  First Circuit· 1999-10-08· cited 440×
• Unnamed case
  Ninth Circuit· 1996-07-17· cited 412×
• In Re Morgan Stanley Information Fund Securities
  Second Circuit· 2010-01-25· cited 364×
• Maldonado v. Dominguez
  First Circuit· 1998-03-02· cited 218×
• Fecht v. Price Co.
  Ninth Circuit· 1995-11-20· cited 160×
• In Re Refco, Inc. Securities Litigation
  S.D. New York· 2007-04-30· cited 154×
• Serabian v. Amoskeag Bank Shares, Inc.
  First Circuit· 1994-05-27· cited 132×
• Gross v. Summa Four, Inc.
  First Circuit· 1996-08-14· cited 128×
• Brody v. Stone & Webster, Inc.
  First Circuit· 2005-07-14· cited 112×
• Plumbers' Union Local No. 12 Pension Fund v. Nomura Asset Acceptance Corp.
  First Circuit· 2011-01-21· cited 91×
• Silverstrand Investments v. Amag Pharmaceuticals, Inc.
  First Circuit· 2013-02-04· cited 88×
• In Re Boston Scientific Corp. Securities Litigation
  First Circuit· 2012-07-12· cited 68×
• Lirette v. Shiva Corp.
  D. Massachusetts· 1998-11-19· cited 60×
• Bradley v. ARIAD Pharmaceuticals, Inc.
  First Circuit· 2016-11-28· cited 50×